The CALHM1 P86L polymorphism is a genetic modifier of age at onset in Alzheimer's disease: a meta-analysis study
- PMID: 20847397
- PMCID: PMC2964875
- DOI: 10.3233/JAD-2010-100933
The CALHM1 P86L polymorphism is a genetic modifier of age at onset in Alzheimer's disease: a meta-analysis study
Abstract
The only established genetic determinant of non-Mendelian forms of Alzheimer's disease (AD) is the ε4 allele of the apolipoprotein E gene (APOE). Recently, it has been reported that the P86L polymorphism of the calcium homeostasis modulator 1 gene (CALHM1) is associated with the risk of developing AD. In order to independently assess this association, we performed a meta-analysis of 7,873 AD cases and 13,274 controls of Caucasian origin (from a total of 24 centers in Belgium, Finland, France, Italy, Spain, Sweden, the UK, and the USA). Our results indicate that the CALHM1 P86L polymorphism is likely not a genetic determinant of AD but may modulate age of onset by interacting with the effect of the ε4 allele of the APOE gene.
Figures
Similar articles
-
Calcium homeostasis modulator 1 gene P86L polymorphism and the risk for alzheimer's disease: A meta-analysis.Neurosci Lett. 2016 Apr 21;619:8-14. doi: 10.1016/j.neulet.2016.02.049. Epub 2016 Mar 2. Neurosci Lett. 2016. PMID: 26944452
-
CALHM1 polymorphism is not associated with late-onset Alzheimer disease.Ann Hum Genet. 2009 May;73(Pt 3):379-81. doi: 10.1111/j.1469-1809.2009.00509.x. Ann Hum Genet. 2009. PMID: 19472444 Free PMC article.
-
Rare variants in calcium homeostasis modulator 1 (CALHM1) found in early onset Alzheimer's disease patients alter calcium homeostasis.PLoS One. 2013 Sep 17;8(9):e74203. doi: 10.1371/journal.pone.0074203. eCollection 2013. PLoS One. 2013. PMID: 24069280 Free PMC article.
-
CALHM1 P86L polymorphism modulates CSF Aβ levels in cognitively healthy individuals at risk for Alzheimer's disease.Mol Med. 2011 Sep-Oct;17(9-10):974-9. doi: 10.2119/molmed.2011.00154. Epub 2011 May 24. Mol Med. 2011. PMID: 21629967 Free PMC article.
-
CALHM1 P86L polymorphism is a risk factor for Alzheimer's disease in the Chinese population.J Alzheimers Dis. 2010;19(1):31-5. doi: 10.3233/JAD-2010-1207. J Alzheimers Dis. 2010. PMID: 20061624
Cited by
-
Epigenetic dysregulation of brainstem nuclei in the pathogenesis of Alzheimer's disease: looking in the correct place at the right time?Cell Mol Life Sci. 2017 Feb;74(3):509-523. doi: 10.1007/s00018-016-2361-4. Epub 2016 Sep 14. Cell Mol Life Sci. 2017. PMID: 27628303 Free PMC article. Review.
-
The NH2 terminus regulates voltage-dependent gating of CALHM ion channels.Am J Physiol Cell Physiol. 2017 Aug 1;313(2):C173-C186. doi: 10.1152/ajpcell.00318.2016. Epub 2017 May 17. Am J Physiol Cell Physiol. 2017. PMID: 28515089 Free PMC article.
-
Cryo-EM structure of the calcium homeostasis modulator 1 channel.Sci Adv. 2020 Jul 17;6(29):eaba8161. doi: 10.1126/sciadv.aba8161. eCollection 2020 Jul. Sci Adv. 2020. PMID: 32832630 Free PMC article.
-
Genetic variability of the gene cluster CALHM 1-3 in sporadic Creutzfeldt-Jakob disease.Prion. 2012 Sep-Oct;6(4):407-12. doi: 10.4161/pri.20785. Epub 2012 Aug 9. Prion. 2012. PMID: 22874670 Free PMC article.
-
CALHM1 controls the Ca²⁺-dependent MEK, ERK, RSK and MSK signaling cascade in neurons.J Cell Sci. 2013 Mar 1;126(Pt 5):1199-206. doi: 10.1242/jcs.117135. Epub 2013 Jan 23. J Cell Sci. 2013. PMID: 23345406 Free PMC article.
References
-
- Hardy J. Amyloid, the presenilins and Alzheimer's disease. Trends Neurosci. 1997;20:154–159. - PubMed
-
- Gatz M, Reynolds CA, Fratiglioni L, Johansson B, Mortimer JA, Berg S, et al. Role of genes and environments for explaining Alzheimer disease. Arch Gen Psychiatry. 2006;63:168–174. - PubMed
-
- Farrer LA, Cupples LA, Haines JL, Hyman B, Kukull WA, Mayeux R, et al. Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium. JAMA. 1997;278:1349–1356. - PubMed
-
- Bertram L, Tanzi RE. Thirty years of Alzheimer's disease genetics: the implications of systematic meta-analyses. Nat Rev Neurosci. 2008;9:768–778. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases
Miscellaneous